About Zenome

• The Zenome project is a decentralized blockchain-driven database of genomic information.


• Zenome platform supports the possibility to manage your genomic data while maintaining privacy and ability to make a profit from selling access to different parts of the genome. Zenome establishes equal conditions for drug development and for the progress of scientific and medical technologies.

• The principal Zenome customers of genetic information are companies interested in genetic targeting such as Google, Facebook, Unilever and pharmaceutical companies.

• Zenome DNA (ZNA) is a utility token on Zenome platform.

• On the Zenome platform user is engaged in many types of different interactions throughout the system. These interactions take place at different system levels, don’t interfere with each other and involve different patterns of interactions. Thus, they should be represented as distinct entities that have different roles.

• The participants who provide resources for the operation of this network receive payments for it in Zenome tokens.

Advisor

Dmitry Kwon

Advisor

Yuri Nikolsky

Advisor in business development

Richard Resnick

Senior advisor

Team Members

Alexey Gorbachev

Ph.D. in molecular biology and biochemistry

Nikolay Kulemin

Ph.D. in bioinformatics

Vladimir Naumov

Genomic data scientist

Sergey Popov

Developer

Arina Anuchina

Researcher

Anastasia Gubina

Project Manager

Alexey Kuzmenkov

Researcher, Ph.D. in biochemistry